Guidelines for the Diagnosis and Management of Arrhythmogenic Right Ventricular Cardiomyopathy

Heart Lung and Circulation

Volumn 20, Issue 12, 2011, Pages 757-760

  Smith, Warren ^a  

^a AUCKLAND CITY HOSPITAL   (New Zealand)

Author keywords

Arrythmias, cardiac; Arrythmogenic right ventricular cardiomyopathy dysplasia; Death, sudden, cardiac; Diagnosis; Echocardiography; Magnetic resonance imaging

Indexed keywords

AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; SOTALOL;

ARTICLE; ASYMPTOMATIC DISEASE; CAUSE OF DEATH; CLINICAL FEATURE; DEFIBRILLATION; DESMOCOLLIN 2 GENE; DESMOGLEIN 2 GENE; DESMOPLAKIN GENE; ELECTROCARDIOGRAPHY; FAMILY ASSESSMENT; FAMILY HISTORY; GENETIC ASSOCIATION; GENETIC COUNSELING; HEART ARREST; HEART RIGHT VENTRICLE DYSPLASIA; HEART VENTRICLE TACHYCARDIA; HUMAN; MUTATIONAL ANALYSIS; MUTATOR GENE; PLAKOGLOBIN GENE; PLAKOPHILIN 2 GENE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; TREATMENT PLANNING;

AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; DEFIBRILLATORS, IMPLANTABLE; DESMOSOMES; ELECTROCARDIOGRAPHY; FEMALE; GENETIC DISEASES, INBORN; HEART ARREST; HUMANS; MALE; MUTATION; PEDIGREE; PLAKOPHILINS; PRACTICE GUIDELINES AS TOPIC; SEX FACTORS; SOTALOL; SURVIVAL RATE; TACHYCARDIA, VENTRICULAR;

EID: 82955232411     PISSN: 14439506     EISSN: 14442892     Source Type: Journal    
DOI: 10.1016/j.hlc.2011.07.019     Document Type: Article

References (9)

1. Asimaki A., Tandri H., Huang H., Halushka M.K., Gautam S., Basso C., et al. A new diagnostic test for arrythmogenic right ventricular cardiomyopathy. N Engl J Med 2009, 360:1075-1084.
2. Dalal D., Nasir K., Bomma C. Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation 2005, 112:3823-3832.
3. Hershberger R., Lindenfeld J., Mestroni L., Seidman C.E., Taylor M.R.G., Towbin J.A. Genetic evaluation of cardiomyopathy-a Heart Failure Society of America practice guideline. J Card Fail 2009, 15:83-97.
4. Hodgkinson K.A., Parfrey P.S., Bassett A.S., Kupprion C., Drenckhahn J., Norman M.W., et al. The impact of implantable cardioverter-defibrillator therapy on survival in autosomal-dominant arrhythmogenic right ventricular cardiomyopathy (ARVD 5). J Am Coll Cardiol 2005, 45:400-407.
5. Marcus F.I., McKenna W.J., Sherrill D., Basso C., Bauce B., Bluemke D.A., et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia. Proposed modification of the Task Force criteria. Eur Heart J 2010, 31:806-814.
6. Quarta G., Muir A., Pantazis A., Syrris P., Gehmlich K., Garcia-Pavia P., et al. Familial evaluation in arrhythmogenic right ventricular cardiomyopathy: impact of genetics and revised task force criteria. Circulation 2011, 123:2701-2709.
7. Sen-Chowdhry S., Syrris P., Ward D., Asimaki A., Sevdalis E., McKenna W.J. Clinical and genetic characterisation of families with arrhythmogenic right ventricular dysplasia/cardiomyopathy provides novel insights into patterns of disease expression. Circulation 2007, 115:1710-1720.
8. Van Tintelen J.P., Hofstra R.M.W., Wiesfeld A.C.P., Van den Berg M.P., Hauer R.N.W., Jongbloed J.D.H. Molecular genetics of arrhythmogenic right ventricular cardiomyopathy: emerging horizon?. Curr Opin Cardiol 2007, 22:185-192.
9. Wichter T., Breithardt G. Implantable cardioverter-defibrillator therapy in arrhythmogenic right ventricular cardiomyopathy. A role for genotyping in decision-making. J Am Coll Cardiol 2005, 45:409-411.